Loading data
CHRNNasdaq
| Unit: USD | FY2026 | FY2025 | FY2025 | FY2024 | FY2024 |
|---|---|---|---|---|---|
| Revenue | 71.6 m USD | — | 84.38 m USD | — | — |
| Cost of revenue | 88.69 m USD | 5.95 m USD | 115.31 m USD | 8.41 m USD | — |
| Gross profit | — | 6.85 m USD | — | 9.51 m USD | — |
| Research and development expense | — | 3.03 m USD | — | 3.87 m USD | — |
| Selling, general and administrative expense | 19.81 m USD | — | 24.81 m USD | — | — |
| Operating profit | -37.5 m USD | -13.33 m USD | -55.33 m USD | -10.46 m USD | — |
| Profit before tax | -49.3 m USD | -11.7 m USD | -72.73 m USD | -11.33 m USD | — |
| Income tax expense | 0 USD | 0 USD | 0 USD | — | — |
| Net income (reported basis) | -50.32 m USD | -11.7 m USD | -11.7 m USD | -11.33 m USD | -11.33 m USD |
| Net income attributable to common shareholders | -50.43 m USD | -11.92 m USD | -72.73 m USD | -11.33 m USD | — |
| Basic earnings per share | -0.36 USD/share | -4.91 USD/share | -0.53 USD/share | -8.43 USD/share | — |
| Diluted earnings per share | -0.36 USD/share | -4.91 USD/share | -0.53 USD/share | -8.43 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.